Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
Cancer Research
|
February 1, 1996
Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers
E C Kohn, E Reed, G Sarosy, et al.
Gynecologic Oncology
|
August 1, 1996
A phase I/II study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy of poor-prognosis advanced-stage epithelial ovarian cancer
E C Kohn, G A Sarosy, P Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1990
Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome
E C Kohn, R G Steis, E A Sausville, et al.
British Journal of Cancer
|
May 18, 2001
Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation
F G Perabo, S Kamp, D Schmidt, et al.
Biotechniques
|
September 20, 2002
Microarray gene expression profiling of angiogenesis inhibitors using the rat aortic ring assay
T G Zogakis, N G Costouros, E A Kruger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction
E C Kohn, E Reed, G A Sarosy, et al.
Endocrine-Related Cancer
|
May 28, 2004
High-resolution serum proteomic features for ovarian cancer detection
T P Conrads, V A Fusaro, S Ross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 13, 2019
Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer
J F Liu, W T Barry, M Birrer, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
Cancer Research
|
February 1, 1996
Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers
E C Kohn, E Reed, G Sarosy, et al.
Gynecologic Oncology
|
August 1, 1996
A phase I/II study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy of poor-prognosis advanced-stage epithelial ovarian cancer
E C Kohn, G A Sarosy, P Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1990
Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome
E C Kohn, R G Steis, E A Sausville, et al.
British Journal of Cancer
|
May 18, 2001
Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation
F G Perabo, S Kamp, D Schmidt, et al.
Biotechniques
|
September 20, 2002
Microarray gene expression profiling of angiogenesis inhibitors using the rat aortic ring assay
T G Zogakis, N G Costouros, E A Kruger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction
E C Kohn, E Reed, G A Sarosy, et al.
Endocrine-Related Cancer
|
May 28, 2004
High-resolution serum proteomic features for ovarian cancer detection
T P Conrads, V A Fusaro, S Ross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 13, 2019
Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer
J F Liu, W T Barry, M Birrer, et al.
Page
of 8